Johnson & Johnson (BVMF:JNJB34)

Market Cap	2.62T
Revenue (ttm)	492.28B
Net Income (ttm)	134.19B
Shares Out	n/a
EPS (ttm)	55.28
PE Ratio	19.55
Forward PE	18.31
Dividend	1.26 (1.74%)
Ex-Dividend Date	Nov 25, 2025

Volume	2,025
Average Volume	5,079
Open	72.71
Previous Close	72.72
Day's Range	72.49 - 73.10
52-Week Range	54.62 - 74.97
Beta	0.36
RSI	64.36
Earnings Date	Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: JNJB34

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD